Key facts
- This page summarizes George Gauthier's Form 4 filing for IGM Biosciences, Inc. (IGMS).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 01 Dec 2023, 19:02.
George Gauthier - 29 Nov 2023 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- IGMS
- Reported as of
- 29 Nov 2023
- Net transaction value
- +$1,403
- SEC form
- 4
- Accepted by SEC
- 01 Dec 2023, 19:02:49 UTC
- Prior SEC filing
- 03 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Misbah Tahir, by power of attorney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
George Gauthier filed Form 4 for IGM Biosciences, Inc. (IGMS) on 01 Dec 2023.
Change
- Previous filing in this sequence was filed on 03 Oct 2023.
- Current net transaction value: +$1,403.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IGMS
transaction
Common Stock
Award
- Transaction value
- $8,735
- Shares
- +1,740
- Change %
- +4.5%
- Price
- $5.02
- Shares after
- 40,822
- Date
- 15 Nov 2023
- Ownership
- Direct
- Footnotes
- F1
IGMS
transaction
Common Stock
Sale
- Transaction value
- $7,331
- Shares
- -1,180
- Change %
- -2.9%
- Price
- $6.21
- Shares after
- 39,642
- Date
- 29 Nov 2023
- Ownership
- Direct
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Footnote F2
These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
Footnote F3
This transaction was executed in multiple trades at prices ranging from $5.79 to $6.45. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.